Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by congo red

被引:176
作者
Podlisny, MB
Walsh, DM
Amarante, P
Ostaszewski, BL
Stimson, ER
Maggio, JE
Teplow, DB
Selkoe, DJ [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Biopolymer Lab, Boston, MA 02115 USA
关键词
D O I
10.1021/bi972029u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid beta-proteins (A beta) are proteolytic fragments of the beta-amyloid precursor protein (beta APP) that are secreted by mammalian cells throughout life but also accumulate progressively as insoluble cerebral aggregates in Alzheimer's disease (AD). Because mounting evidence indicates that A beta aggregation and deposition are early, critical features of AD leading to neurotoxicity, many studies of A beta aggregation have been conducted using synthetic peptides under generally nonphysiological conditions and concentrations. We recently described the oligomerization of A beta peptides secreted by beta APP-expressing cells at low nanomolar (20-30 ng/mL) levels into sodium dodecyl sulfate-(SDS-) stable oligomers of 6-16 kDa. Here, we extensively characterize this in vitro system and show that the amyloid binding dye, Congo red, acts to markedly decrease oligomer/monomer ratios by stabilizing the 4 kDa A beta monomers (ID50 congruent to 3.4 mu M). Addition of radioiodinated synthetic A beta(1-40) to the cultures or to their conditioned media at physiological concentrations (0.25-2.5 nM) reveals that it undergoes progressive aggregation into SDS-stable oligomers of 6-25 kDa during brief (similar to 4 h) incubation at 37 degrees C, and this is inhibitable by Congo red. The level of A beta oligomers can be quantitated in the Chinese hamster ovary (CHO) conditioned medium by size-exclusion chromatography as well as by SDS-polyacrylamide gel electrophoresis (PAGE), and comparison of these two methods suggests that aggregation of A beta into higher molecular weight polymers that are not detectable by SDS-PAGE occurs in the cultures. We conclude that both endogenous and synthetic A beta can assemble into stable oligomers at physiological concentrations in cell culture, providing a manipulable system for studying the mechanism of early A beta aggregation and identifying inhibitors thereof under biologically relevant conditions.
引用
收藏
页码:3602 / 3611
页数:10
相关论文
共 55 条
[41]   Morphology and toxicity of A beta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease [J].
Roher, AE ;
Chaney, MO ;
Kuo, YM ;
Webster, SD ;
Stine, WB ;
Haverkamp, LJ ;
Woods, AS ;
Cotter, RJ ;
Tuohy, JM ;
Krafft, GA ;
Bonnell, BS ;
Emmerling, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20631-20635
[42]   Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [J].
Scheuner, D ;
Eckman, C ;
Jensen, M ;
Song, X ;
Citron, M ;
Suzuki, N ;
Bird, TD ;
Hardy, J ;
Hutton, M ;
Kukull, W ;
Larson, E ;
LevyLahad, E ;
Viitanen, M ;
Peskind, E ;
Poorkaj, P ;
Schellenberg, G ;
Tanzi, R ;
Wasco, W ;
Lannfelt, L ;
Selkoe, D ;
Younkin, S .
NATURE MEDICINE, 1996, 2 (08) :864-870
[43]   INCREASED AMYLOID BETA-PEPTIDE DEPOSITION IN CEREBRAL-CORTEX AS A CONSEQUENCE OF APOLIPOPROTEIN-E GENOTYPE IN LATE-ONSET ALZHEIMER-DISEASE [J].
SCHMECHEL, DE ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
CRAIN, BJ ;
HULETTE, CM ;
JOO, SH ;
PERICAKVANCE, MA ;
GOLDGABER, D ;
ROSES, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (20) :9649-9653
[44]   Amyloid beta-protein and the genetics of Alzheimer's disease [J].
Selkoe, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18295-18298
[45]   ISOLATION AND QUANTIFICATION OF SOLUBLE ALZHEIMERS BETA-PEPTIDE FROM BIOLOGICAL-FLUIDS [J].
SEUBERT, P ;
VIGOPELFREY, C ;
ESCH, F ;
LEE, M ;
DOVEY, H ;
DAVIS, D ;
SINHA, S ;
SCHLOSSMACHER, M ;
WHALEY, J ;
SWINDLEHURST, C ;
MCCORMACK, R ;
WOLFERT, R ;
SELKOE, D ;
LIEBERBURG, I ;
SCHENK, D .
NATURE, 1992, 359 (6393) :325-327
[46]   PRODUCTION OF THE ALZHEIMER AMYLOID-BETA PROTEIN BY NORMAL PROTEOLYTIC PROCESSING [J].
SHOJI, M ;
GOLDE, TE ;
GHISO, J ;
CHEUNG, TT ;
ESTUS, S ;
SHAFFER, LM ;
CAI, XD ;
MCKAY, DM ;
TINTNER, R ;
FRANGIONE, B ;
YOUNKIN, SG .
SCIENCE, 1992, 258 (5079) :126-129
[47]   AMYLOID-BETA AGGREGATION - SELECTIVE-INHIBITION OF AGGREGATION IN MIXTURES OF AMYLOID WITH DIFFERENT CHAIN LENGTHS [J].
SNYDER, SW ;
LADROR, US ;
WADE, WS ;
WANG, GT ;
BARRETT, LW ;
MATAYOSHI, ED ;
HUFFAKER, HJ ;
KRAFFT, GA ;
HOLZMAN, TF .
BIOPHYSICAL JOURNAL, 1994, 67 (03) :1216-1228
[48]   AN INCREASED PERCENTAGE OF LONG AMYLOID-BETA PROTEIN SECRETED BY FAMILIAL AMYLOID-BETA PROTEIN-PRECURSOR (BETA-APP(717)) MUTANTS [J].
SUZUKI, N ;
CHEUNG, TT ;
CAI, XD ;
ODAKA, A ;
OTVOS, L ;
ECKMAN, C ;
GOLDE, TE ;
YOUNKIN, SG .
SCIENCE, 1994, 264 (5163) :1336-1340
[49]   PREAMYLOID DEPOSITS IN THE CEREBRAL-CORTEX OF PATIENTS WITH ALZHEIMERS-DISEASE AND NONDEMENTED INDIVIDUALS [J].
TAGLIAVINI, F ;
GIACCONE, G ;
FRANGIONE, B ;
BUGIANI, O .
NEUROSCIENCE LETTERS, 1988, 93 (2-3) :191-196
[50]  
TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205